Today, many genotyping workflows rely on bulk sequencing assays. Although this approach has enabled numerous advances in biotechnology over the last decade, these assays do not preserve the information of individual cells and is therefore limited in its scope to recognise true biological complexity. Indeed, one may argue that the cure of human malignancies will require eradication of multiple co-occurring subclones, a feat only achievable through a single-cell analysis.

Mission Bio's Tapestri platform allows single-cell multi-omics analysis with simultaneous detection of SNVs, CNVs, and cell-surface proteins, therefore enabling researchers to accurately characterise the mutational landscape of a population and reveal the impact of co-mutations and zygosity state on cell-surface protein expression. Key applications of the Tapestri's Platform include characterising clonal heterogeneity and clonal evolution, improving patient stratification, and guiding adaptive and rational combination therapies for improving patient outcomes. This single-cell multi-omics approach provides the sensitivity and resolution required to enhance biomarker discovery, better explore mechanisms of action, monitor patients, and untangle therapy resistance mechanisms that are impossible to obtain through traditional methodologies.

In this seminar, we will present:

- An overview of Mission Bio’s technology
  and offering

- Examples of applications (monitoring MRD,
   resolving clonal heterogeneity, assessing DNA
   methylation profile, etc.)

- Our users’ published studies to identify tumor
   resistance mechanisms, stratification of cancer
   patients, etc.


Date: Thursday, September 14th, 2023
Time: 12:00 - 13:00h
Room: BBS conference room (Carreire)

  Matteo Cattaneo
Field Application Specialist

Matteo Cattaneo is a scientist with a background in Molecular Biology and Genetics. He holds a PhD in Biology from the University of Grenoble. During his thesis, he studied gene expression regulation with a focus on Epigenetics mechanisms and Cancer. He has years of experience supporting customer projects using a variety of tools and products. He is currently working as an Application Scientist and helps researchers and clinicians dissect biological heterogeneity using Mission Bio’s multi-omics single-cell technology. 
  Stéphane Colinet
Sales Executive France, Mission Bio


As we will offer food & drinks, please register

Read our GDPR insert in our Privacy Policy